Get the Stockscreener App
35.83
2.26%
-0.83
Pre-market:
36.00
0.17
+0.47%
First Tracks Biotherapeutics Inc stock is traded at $35.83, with a volume of 1.14M.
It is down -2.26% in the last 24 hours and down -17.21% over the past month.
First Tracks Biotherapeutics Inc is a clinical-stage biotechnology company focused on delivering immunology therapeutics for autoimmune and inflammatory diseases. Its clinical-stage pipeline includes rosnilimab, a selective pathogenic T cell depleter, for which it completed a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA), ANB033, a CD122 antagonist, in a Phase 1b trial for celiac disease (CeD) and eosinophilic esophagitis (EoE), and ANB101, a BDCA2 modulator, in a Phase 1a trial. The company operates in one reportable segment focused on research and development activities to deliver immunology therapeutics for autoimmune and inflammatory diseases.
See More
Previous Close:
$36.66
Open:
$36.11
24h Volume:
1.14M
Relative Volume:
1.47
Market Cap:
$1.28B
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-8.60%
1M Performance:
-17.21%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$34.57
$37.09
1-Week Range:
$34.57
$42.24
52-Week Range:
$14.72
$49.91
First Tracks Biotherapeutics Inc Stock (TRAX) Company Profile
Name
First Tracks Biotherapeutics Inc
Sector
Industry
Phone
212-373-3000
Address
10770 WATERIDGE CIRCLE, SAN DIEGO
Compare TRAX vs VRTX, REGN, MRNA, ARGX, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TRAX
First Tracks Biotherapeutics Inc
|
35.83 | 1.28B | 0 | 0 | 0 | 0.00 |
VRTX
Vertex Pharmaceuticals Inc
|
522.38 | 132.40B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
796.02 | 81.95B | 14.92B | 4.42B | 3.79B | 41.04 |
MRNA
Moderna Inc
|
194.82 | 77.78B | 2.23B | -3.19B | -1.60B | -8.1462 |
ARGX
Argen X Se Adr
|
962.22 | 60.20B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
199.86 | 42.84B | 742.00K | -1.37B | -1.07B | -7.0731 |
First Tracks Biotherapeutics Inc Stock (TRAX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-24-26 | Initiated | Leerink Partners | Outperform |
| Apr-24-26 | Initiated | Wedbush | Outperform |
| Apr-23-26 | Initiated | JP Morgan | Overweight |
| Apr-22-26 | Initiated | Barclays | Overweight |
| Apr-21-26 | Initiated | UBS | Buy |
First Tracks Biotherapeutics Inc Stock (TRAX) Latest News
State Street Corp Buys 1,512,896 Shares of First Tracks Biotherapeutics $TRAX - MarketBeat
Spin-off leaves AnaptysBio (ANAB) a lean royalty firm - Stock Titan
Anaptys Announces Second Quarter and Transitional Fiscal - GlobeNewswire
Why Did CRCL Stock Lose Steam? Wall Street Split On Circle’s Banking Win - Stocktwits
First Tracks Biotherapeutics Inc (TRAX) Stock Price, Quote, News & History - Benzinga
This Cue Biopharma Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Benzinga
Evercore Initiates First Tracks Biotherapeutics(TRAX.US) With Buy Rating, Announces Target Price $65 - Moomoo
John Orwin (TRAX) lifts direct stake to 17,995 shares - Stock Titan
First Tracks Biotherapeutics (NASDAQ:TRAX) Stock Rating Upgraded by Guggenheim - MarketBeat
Why is First Tracks Biotherapeutics stock rallying today? By Investing.com - Investing.com Canada
First Tracks Biotherapeutics stock rises on Guggenheim buy rating - Investing.com
First Tracks Biotherapeutics stock rises on Guggenheim buy rating By Investing.com - Investing.com Canada
Guggenheim initiates coverage of First Tracks with Buy rating, $100 price target - TradingView
Guggenheim initiates First Tracks stock with buy on autoimmune drug potential - Investing.com Canada
First Tracks Biotherapeutics Inc Actuals & Estimates (NASDAQ:TRAX) - TradingView
Basic earnings per share (basic EPS) of First Tracks Biotherapeutics Inc – FWB:B43 - TradingView
First Tracks Biotherapeutics Inc Cash Flow – FWB:B43 - TradingView
ETFs Investing in First Tracks Biotherapeutics Inc Stocks - TradingView
First Tracks Biotherapeutics at wells fargo healthcare conference: data loom By Investing.com - Investing.com South Africa
First Tracks Biotherapeutics Insider Ware J. Anthony Sells 39,265 Shares at $44.78 Following Option Exercise - Kalkine Media
TRAX Price Today: First Tracks Biotherapeutics, Inc. Stock Price, Quote & Chart | MEXC - MEXC
First Tracks Biotherapeutics Director Sold Shares Worth Over $1.7M - TradingView
First Tracks Biotherapeutics (TRAX) director sells shares after option exercise - Stock Titan
H.C. Wainwright Maintains First Tracks Biotherapeutics(TRAX.US) With Buy Rating, Maintains Target Price $57 - Moomoo
TRAX Reiterates by First Tracks -- Price Target Maintained at $5 - GuruFocus
Long term debt to total assets ratio of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Which stocks are gapping on Wednesday? - ChartMill
Dell, Gitlab surge 11-14% on strong Q2 results; Sirius XM rises - scanx.trade
Cash flow from operating activities of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
EBIT per share of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Revenue per share of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Tangible book value per share of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Return on assets % of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Price to book ratio of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - tradingview.com
Total debt of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
After tax other income/expense of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
First Tracks Biotherapeutics Announces Participation in September Investor Conferences - finance.yahoo.com
Non-controlling/minority interest of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Total liabilities of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Taxes of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Diluted shares outstanding of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Total operating expenses of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Diluted earnings per share (diluted EPS) of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - tradingview.com
First Tracks Biotherapeutics, Inc. Revenue Breakdown – NASDAQ:TRAX - TradingView
Total revenue of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - tradingview.com
Dilution adjustment of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Price to cash flow ratio of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
CapEx per share of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Number of shareholders of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Enterprise value to EBITDA forward of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - tradingview.com
Net debt of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
First Tracks Biotherapeutics Inc Stock (TRAX) Financials Data
There is no financial data for First Tracks Biotherapeutics Inc (TRAX). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
1.11%
1.87%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):